<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">60771</article-id><article-id pub-id-type="doi">10.7554/eLife.60771</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>CB<sub>1</sub>R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-199516"><name><surname>Drori</surname><given-names>Adi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-199517"><name><surname>Gammal</surname><given-names>Asaad</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-199518"><name><surname>Azar</surname><given-names>Shahar</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-199519"><name><surname>Hinden</surname><given-names>Liad</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0307-4350</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-199520"><name><surname>Hadar</surname><given-names>Rivka</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-199521"><name><surname>Wesley</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-199522"><name><surname>Nemirovski</surname><given-names>Alina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-199523"><name><surname>Szanda</surname><given-names>Gergő</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-126463"><name><surname>Salton</surname><given-names>Maayan</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-7248"><name><surname>Tirosh</surname><given-names>Boaz</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8067-6577</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-69175"><name><surname>Tam</surname><given-names>Joseph</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0948-0093</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Institute for Drug Research, School of Pharmacy, Faculty of Medicine</institution>, <institution>The Hebrew University of Jerusalem</institution>, <addr-line><named-content content-type="city">Jerusalem</named-content></addr-line>, <country>Israel</country></aff><aff id="aff2"><institution content-type="dept">Laboratory of Physiological Studies</institution>, <institution>National Institute on Alcohol Abuse &amp; Alcoholism</institution>, <addr-line><named-content content-type="city">Bethesda</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Physiology</institution>, <institution>Semmelweis University</institution>, <addr-line><named-content content-type="city">Budapest</named-content></addr-line>, <country>Hungary</country></aff><aff id="aff4"><institution content-type="dept">Biochemistry and molecular biology</institution>, <institution>Hebrew University of Jerusalem</institution>, <addr-line><named-content content-type="city">Jerusalem</named-content></addr-line>, <country>Israel</country></aff><aff id="aff5"><institution content-type="dept">The Institute for Drug Research, School of Pharmacy, Faculty of Medicine</institution>, <institution>The Hebrew University of Jerusalem</institution>, <addr-line><named-content content-type="city">Jerusalem</named-content></addr-line>, <country>Israel</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-143521"><name><surname>Diehl</surname><given-names>Anna Mae</given-names></name><role>Reviewing editor</role><aff><institution>Duke University School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>yossit@ekmd.huji.ac.il</email> (JT);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>11</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e60771</elocation-id><history><date date-type="received"><day>06</day><month>07</month><year>2020</year></date><date date-type="accepted"><day>17</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Drori et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Drori et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-60771-v1.pdf"/><abstract><p>The soluble isoform of leptin receptor (sOb-R), secreted by the liver, regulates leptin bioavailability and bioactivity. Its reduced levels in diet-induced obesity (DIO) contribute to hyperleptinemia and leptin resistance, effects that are regulated by the endocannabinoid (eCB)/CB<sub>1</sub>R system. Here we show that pharmacological activation/blockade and genetic overexpression/deletion of hepatic CB<sub>1</sub>R modulates sOb-R levels and hepatic leptin resistance. Interestingly, peripheral CB<sub>1</sub>R blockade failed to reverse DIO-induced reduction of sOb-R levels, increased fat mass and dyslipidemia, and hepatic steatosis in mice lacking C/EBP homologous protein (CHOP), whereas direct activation of CB<sub>1</sub>R in wild-type hepatocytes reduced sOb-R levels in a CHOP-dependent manner. Moreover, CHOP stimulation increased sOb-R expression and release via a direct regulation of its promoter, while CHOP deletion reduced leptin sensitivity. Our findings highlight a novel molecular aspect by which the hepatic eCB/CB<sub>1</sub>R system is involved in the development of hepatic leptin resistance and in the regulation of sOb-R levels via CHOP.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003977</institution-id><institution>Israel Science Foundation</institution></institution-wrap></funding-source><award-id>617/14</award-id><principal-award-recipient><name><surname>Tam</surname><given-names>Joseph</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003977</institution-id><institution>Israel Science Foundation</institution></institution-wrap></funding-source><award-id>158/18</award-id><principal-award-recipient><name><surname>Tam</surname><given-names>Joseph</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>The Obesity Society's Early Career Research Award</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Tam</surname><given-names>Joseph</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>ERC-2015-StG grant</institution></institution-wrap></funding-source><award-id>676841</award-id><principal-award-recipient><name><surname>Tam</surname><given-names>Joseph</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>Hungarian National Research, Development, and Innovation Office</institution></institution-wrap></funding-source><award-id>NKFI-6/FK_124038</award-id><principal-award-recipient><name><surname>Szanda</surname><given-names>Gergő</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal studies were approved by the Institutional Animal Care and Use Committee of the Hebrew University of Jerusalem (AAALAC accreditation #1285; Ethic approval numbers MD-14-14008 &amp; MD-19-15951). Animal studies are reported in compliance with the ARRIVE guidelines (Kilkenny et al., 2010), and are based on the rule of the replacement, refinement, or reduction. All the animals used in this study were housed under specific pathogen‐free (SPF) conditions, up to five per cage, in standard plastic cages with natural soft sawdust as bedding. The animals were maintained under controlled temperature of 22-24{degree sign}C, humidity at 55 {plus minus} 5%, and alternating 12-hour light/dark cycles (lights were on between 7:00 and 19:00 hr), and provided with food and water ad libitum.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for all figures.</p></sec><supplementary-material><ext-link xlink:href="elife-60771-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>